Cited by 65HIV Research and TreatmentVirus-based gene therapy researchHIV/AIDS drug development and treatment

The cleavage and polyadenylation specificity factor 6 (CPSF6) subunit of the capsid-recruited pre-messenger RNA cleavage factor I (CFIm) complex mediates HIV-1 integration into genes

Open access
Rasheedi, Sheeba, Shun, Ming-Chieh, Serrao, Erik, Sowd, Gregory A., Qian, Juan, Hao, Caili, Dasgupta, Twishasri, Engelman, Alan N. +1 more·2016·Journal of Biological Chemistry

Abstract

HIV-1 favors integration into active genes and gene-enriched regions of host cell chromosomes, thus maximizing the probability of provirus expression immediately after integration. This requires cleavage and polyadenylation specificity factor 6 (CPSF6), a cellular protein involved in pre-mRNA 3' end processing that binds HIV-1 capsid and connects HIV-1 preintegration complexes to intranuclear trafficking pathways that link integration to transcriptionally active chromatin. CPSF6 together with CPSF5 and CPSF7 are known subunits of the cleavage factor I (CFIm) 3' end processing complex; however, CPSF6 could participate in additional protein complexes. The molecular mechanisms underpinning the role of CPSF6 in HIV-1 infection remain to be defined. Here, we show that a majority of cellular CPSF6 is incorporated into the CFIm complex. HIV-1 capsid recruits CFIm in a CPSF6-dependent manner, which suggests that the CFIm complex mediates the known effects of CPSF6 in HIV-1 infection. To dissect the roles of CPSF6 and other CFIm complex subunits in HIV-1 infection, we analyzed virologic and integration site targeting properties of a CPSF6 variant with mutations that prevent its incorporation into CFIm We show, somewhat surprisingly, that CPSF6 incorporation into CFIm is not required for its ability to direct preferential HIV-1 integration into genes. The CPSF5 and CPSF7 subunits appear to have only a minor, if any, role in this process even though they appear to facilitate CPSF6 binding to capsid. Thus, CPSF6 alone controls the key molecular interactions that specify HIV-1 preintegration complex trafficking to active chromatin.

Integrity signals

Registry

Crossref · 10.1074/jbc.m116.721647

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • CPSF6 facilitates targeting of HIV-1 PICs to transcriptionally active regions of the genome found deep within the center of the nucleus.

    “Another important host factor identified in retroviral integration is CPSF6 that facilitates targeting of the HIV-1 PICs to transcriptionally active regions of the genome found deep within the center of the nucleus (Rasheedi et al. 2016, Achuthan et al. 2018, Singh et al. 2022a).”

The citation lists haven’t been fetched yet

References 54 · Cited by 65

Authors
Rasheedi, S., Shun, M.-C., Serrao, E., Sowd, G. A., Qian, J., Hao, C., Dasgupta, T., Engelman, A. N., & Skowronski, J.
Affiliations
  • Case Western Reserve University (US)
  • Dana-Farber Cancer Institute (US)
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2016-05
Volume
291
Issue
22
Pages
11809-11819
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2308758579
Cited by
65
References
54
Citations by year
2026: 2 · 2025: 6 · 2024: 8 · 2023: 5 · 2022: 5 · 2021: 5 · 2020: 5 · 2019: 8 · 2018: 13 · 2017: 3 · 2016: 5
FWCI
6.70
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute of Allergy and Infectious Diseases (P30 AI036219)
  • National Institute of General Medical Sciences (P50 GM082251)
Topics
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
Keywords
CPSF6, cleavage factor I, HIV-1 integration, preintegration complex, HIV-1 capsid, pre-mRNA 3' end processing, chromatin targeting
MeSH terms
Capsid, Humans, RNA Precursors, RNA, Messenger, HIV-1, HIV Infections, Virus Integration, mRNA Cleavage and Polyadenylation Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review